Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
Nathanson+Hauck

2. Address

Address1
601 13th Street NW
 Address2
​Suite 290 North
City
Washington
 State
DC
 Zip Code
20005
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Ms.
​Melanie Nathanson
​2022589381
​mnathanson@n-hdc.com
5. Senate ID#
​400693064-63
7. Client Name Self Check if client is a state or local government or instrumentality
​Pew Charitable Trusts
6. House ID#
​415240005
TYPE OF REPORT 8. Year
​2020
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​60,000.00
$5,000 or more $
​
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Melanie Nathanson
 Date
10/11/2020 9:06:20 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

S. 4760 - Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act - Strategies to address problems related to treating currently antibiotic resistant diseases and infections.

H.R. 8406 - The HEROES ACT (modified) - Issues related to substance use disorder, innovation in the antibiotics space and data-related policies in response to the COVID-19 pandemic.

Senate HEALS Act - Issues related to substance use disorder, innovation in the antibiotics space and data-related policies in response to the COVID-19 pandemic.

S. 6725 - The National Defense Authorization Act - Issues related to ensuring that there are antibiotics in the pipeline to ensure that our nation's troops are adequately protected from infection-related complications.

H.R. 6800 - THe HEROES Act - Issues related to continuing the fight against SUD and opioid addiction in the time of COVID. Issues related to ensuring that there were new, effective antibiotics in the pipeline to treat secondary infections due to hospitalizations for COVID. Issues related to HIT as a tool during the pandemic.

H.R. 748 - CARES Act -Implementation- Issues related to supporting the national work fighting COVID-19 and ensuring that antibiotics are available during the COVID-19 crisis and beyond and OTC monograph reform is address to enhance patient safety.

H.R. 6201 - Families First Coronavirus Response Act - Implementation- Issues related to ensuring that the federal government is best supporting the public good with a focus on ensuring there is a strong antibiotics pipeline to fight secondary infections and over the counter medications are safe and secure.

H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 -Implementation- Issues related to supporting programs and institutions supporting during the current pandemic.

S. 1712/H.R. 4100 - THe DISARM Act - Support for ensuring that there are sufficient antibiotics in the pipeline to meet the national need.

H.R. 2482 - The Mainstreaming Addiction Treatment Act of 2019 - Support for policies increasing the ability to access MAT to treat addiction.

Regulations promulgated by ONC and HHS related to patient matching, interoperability, unique patient identifiers, unique device identifiers and other HIT tools that can support better patient safety in our healthcare system.

Issues related to creating a listing mechanism for dietary supplements.

Issues related to the implementation on the SUPPORT Act (P.L. 115-271)



17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Melanie
Nathanson
​
​
Megan
Hauck
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 8406 - The HEROES ACT (modified) - Issues related to substance use disorder, innovation in the antibiotics space and data-related policies in response to the COVID-19 pandemic.

Senate HEALS Act - Issues related to substance use disorder, innovation in the antibiotics space and data-related policies in response to the COVID-19 pandemic.

S. 6725 - The National Defense Authorization Act - Issues related to ensuring that there are antibiotics in the pipeline to ensure that our nation's troops are adequately protected from infection-related complications.

H.R. 6800 - THe HEROES Act - Issues related to continuing the fight against SUD and opioid addiction in the time of COVID for Medicare and Medicaid beneficiaries. Issues related to ensuring that there were new, effective antibiotics in the pipeline to treat secondary infections due to hospitalizations for COVID. Issues related to HIT as a tool during the pandemic.

H.R. 2482 - The Mainstreaming Addiction Treatment Act of 2019 - Support for policies increasing the ability to access MAT to treat addiction for Medicare and Medicaid beneficiaries.

Regulations promulgated by ONC and HHS related to patient matching, interoperability, unique patient identifiers, unique device identifiers and other HIT tools that can support better patient safety in the Medicare and Medicaid systems.

Issues related to the implementation on the SUPPORT Act (P.L. 115-271) as they relate to curbing opioid abuse and substance use disorder for Medicare beneficiaries.



17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Melanie
Nathanson
​
​
Megan
Hauck
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

S. 4760 - Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act - Strategies to address problems related to treating currently antibiotic resistant diseases and infections.

S. 6725 - The National Defense Authorization Act - Issues related to ensuring that there are antibiotics in the pipeline to ensure that our nation's troops are adequately protected from infection-related complications.

H.R. 6800 - THe HEROES Act - Issues related to continuing the fight against SUD and opioid addiction in the time of COVID. Issues related to ensuring that there were new, effective antibiotics in the pipeline to treat secondary infections due to hospitalizations for COVID. Issues related to HIT as a tool during the pandemic.


H.R. 748 - CARES Act - Implementation - Issues related to supporting the national work fighting COVID-19 and ensuring that antibiotics are available during the COVID-19 crisis and beyond and OTC monograph reform is address to enhance patient safety.

H.R. 6201 - Families First Coronavirus Response Act - Implementation- Issues related to ensuring that the federal government is best supporting the public good with a focus on ensuring there is a strong antibiotics pipeline to fight secondary infections and over the counter medications are safe and secure.

H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 -Implementation - Issues related to supporting programs and institutions supporting during the current pandemic.

S. 1712/H.R. 4100 - THe DISARM Act - Support for ensuring that there are sufficient antibiotics in the pipeline to meet the national need.

H.R. 2482 - The Mainstreaming Addiction Treatment Act of 2019 - Support for policies increasing the ability to access MAT to treat addiction.

Issues related to creating a listing mechanism for dietary supplements.

Issues related to the implementation on the SUPPORT Act (P.L. 115-271)






17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Melanie
Nathanson
​
​
Megan
Hauck
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)